Smith & Nephew plc
HealthcareNYSE:SNN · New York Stock Exchange
-$0.10 today
Vol 0.65M · Avg 1.08M
Balance Sheet
Inspect the capital base behind the business
Review assets, liabilities, equity, cash, and debt to judge whether the company has the financial position to support future returns.
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $557.0M |
| Receivables | $1.4B |
| Inventory | $2.1B |
| Total Current Assets | $4.1B |
| PP&E (Net) | $1.6B |
| Goodwill | $3.1B |
| Intangible Assets | $882.0M |
| Long-term Investments | $151.0M |
| Tax Assets | $347.0M |
| Other Non-current | $228.0M |
| Total Non-current Assets | $6.4B |
| Total Assets | $10.5B |
Analysis
Selected assets total $10.5B for Latest. The largest visible component is Goodwill at $3.1B, about 29.7% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Balance Sheet
Annual data · 5 periods
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $557.0M -10.0% | $619.0M +105.0% | $302.0M -13.7% | $350.0M -72.9% | $1.3B | $1.0B | $841.8M | $673.8M |
| Short-term Investments | $0 | $0 | $0 | $0 | $0 | -$1.6B | $445.6M | $378.4M |
| Net Receivables | $1.4B +18.4% | $1.2B +14.0% | $1.1B +3.1% | $1.0B +5.8% | $971.0M | $533.8M | $399.4M | -$1.7B |
| Inventory | $2.1B -11.3% | $2.4B -0.3% | $2.4B +8.6% | $2.2B +19.6% | $1.8B | $641.6M | $328.0M | $316.8M |
| Other Current Assets | $0 -100.0% | $81.0M -55.5% | $182.0M -8.1% | $198.0M -17.5% | $240.0M | $1.5B | $966.4M | $764.8M |
| Total Current Assets | $4.1B -7.2% | $4.4B +9.7% | $4.0B +4.5% | $3.9B -12.8% | $4.4B | $12.5B | $10.5B | $5.5B |
| Property, Plant & Equipment (Net) | $1.6B +15.2% | $1.4B -3.3% | $1.5B +1.0% | $1.5B -3.8% | $1.5B | $1.2B | $1.5B | $687.8M |
| Goodwill | $3.1B +2.7% | $3.0B +1.1% | $3.0B -1.3% | $3.0B +1.4% | $3.0B | $925.8M | $466.6M | $309.8M |
| Intangible Assets | $882.0M -14.5% | $1.0B -7.0% | $1.1B -10.2% | $1.2B -11.6% | $1.4B | $568.8M | $860.0M | $1.5B |
| Long-term Investments | $151.0M +843.8% | $16.0M -33.3% | $24.0M -58.6% | $58.0M -84.7% | $380.0M | $524.0M | -$1.5B | $860.0M |
| Tax Assets | $347.0M +3.9% | $334.0M | $0 -100.0% | $177.0M -11.9% | $201.0M | $1.5B | $1.4B | $1.4B |
| Other Non-current Assets | $228.0M +121.4% | $103.0M -71.5% | $361.0M +135.9% | $153.0M +920.0% | $15.0M | $1.4B | $1.0B | $679.4M |
| Total Non-current Assets | $6.4B +7.1% | $5.9B -0.4% | $6.0B -2.5% | $6.1B -5.9% | $6.5B | -$15.3B | $14.8B | $11.3B |
| Total Assets | $10.5B +1.0% | $10.4B +3.7% | $10.0B +0.2% | $10.0B -8.7% | $10.9B | $13.3B | $11.9B | $10.6B |
| Account Payables | $1.2B +8.8% | $1.1B +6.5% | $1.0B -1.3% | $1.0B -1.3% | $1.0B | $1.3B | -$1.5B | $1.4B |
| Short-term Debt | $150.0M +7400.0% | $2.0M -99.7% | $710.0M +539.6% | $111.0M -74.5% | $435.0M | -$1.6B | -$1.6B | $326.6M |
| Tax Payables | $0 -100.0% | $232.0M +6.4% | $218.0M +1.9% | $214.0M -3.6% | $222.0M | $574.4M | -$1.5B | $1.4B |
| Deferred Revenue | $0 | $0 | $0 | $0 | $0 | -$1.6B | $374.2M | $542.2M |
| Other Current Liabilities | $74.0M -41.3% | $126.0M -51.7% | $261.0M -50.4% | $526.0M -11.9% | $597.0M | $1.1B | $1.5B | $493.2M |
| Total Current Liabilities | $1.6B +4.2% | $1.5B -32.6% | $2.3B +32.4% | $1.7B -19.5% | $2.1B | $6.0B | $10.1B | $14.3B |
| Long-term Debt | $3.0B -3.0% | $3.1B +43.6% | $2.2B -15.2% | $2.6B -5.2% | $2.7B | $1.3B | $438.6M | $1.3B |
| Deferred Tax Liabilities | $40.0M | $0 | $0 -100.0% | $36.0M -75.0% | $144.0M | $746.6M | $612.2M | $477.8M |
| Deferred Revenue (Non-current) | $0 | $0 | $0 | $0 | $0 | -$1.6B | $715.8M | $1.3B |
| Other Non-current Liabilities | $356.0M +18.7% | $300.0M +66.7% | $180.0M -26.2% | $244.0M +6.6% | $229.0M | $489.0M | $1.1B | -$1.5B |
| Total Non-current Liabilities | $3.6B +0.4% | $3.6B +42.4% | $2.5B -16.5% | $3.0B -7.1% | $3.2B | $3.9B | $7.5B | $14.1B |
| Total Liabilities | $5.2B +1.6% | $5.1B +6.7% | $4.8B +1.3% | $4.7B -12.1% | $5.4B | $14.7B | $3.7B | $9.6B |
| Common Stock | $175.0M +0.0% | $175.0M +0.0% | $175.0M +0.0% | $175.0M -1.1% | $177.0M | $651.4M | $517.0M | $382.6M |
| Retained Earnings | $5.3B +6.1% | $5.0B +2.3% | $4.9B -2.4% | $5.0B -3.8% | $5.2B | -$1.6B | $519.8M | $1.1B |
| Accumulated OCI | $20.0M | $0 +100.0% | -$385.0M +12.3% | -$439.0M -33.8% | -$328.0M | $393.8M | $550.6M | $707.4M |
| Other Stockholders Equity | -$329.0M +33.8% | -$497.0M | $0 | $0 | $0 | $351.8M | -$1.6B | $1.5B |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $1.4B | $337.8M | $931.4M |
| Total Equity | $5.3B +0.5% | $5.3B +0.9% | $5.2B -0.8% | $5.3B -5.5% | $5.6B | $9.1B | $7.7B | $3.3B |
| Total Debt | $3.3B +0.2% | $3.3B +7.7% | $3.1B +7.4% | $2.9B -14.0% | $3.3B | $724.2M | $410.6M | $399.4M |
| Net Debt | $2.8B +2.5% | $2.7B -2.9% | $2.8B +10.3% | $2.5B +23.1% | $2.0B | $389.6M | $501.6M | $311.2M |
Older periods hidden.
Sign in to unlockCompetitors
Peer companies in the same sector
Centene Corporation
NYSE:CNC
$32.19B
Royalty Pharma plc
NASDAQ:RPRX
$23.60B
Zimmer Biomet Holdings, Inc.
NYSE:ZBH
$17.13B
Hologic, Inc.
HOLX
$16.97B
Neurocrine Biosciences, Inc.
NASDAQ:NBIX
$16.06B
Tenet Healthcare Corporation
NYSE:THC
$15.04B
Medpace Holdings, Inc.
NASDAQ:MEDP
$13.35B
The Cooper Companies, Inc.
NASDAQ:COO
$13.24B
Fresenius Medical Care AG & Co. KGaA
NYSE:FMS
$12.36B
Tempus AI, Inc.
NASDAQ:TEM
$8.35B
SEC Filings
Recent regulatory filings
No filings found.
How much cash does SNN have?
Smith & Nephew plc (SNN) reported $557.00M in cash and equivalents in fiscal 2025.
How much debt does SNN carry?
Smith & Nephew plc (SNN) reported $3.33B of total debt, with net debt of $2.77B.
Explore More
Continue the stock analysis
Jump to another research area for this company.